Repeat order represents over $13 million in purchases by this end user with further plans to add incremental batteries to their existing facilities as well as batteries for new construction sites
Read More
The United Kingdom is the world's 3rd largest fitness market
New UK Partner, Cranlea Human Performance, has sold CLMBRs to leading UK health clubs, including David Lloyd Clubs
Cranlea's 50-Year History and Leading In-Market Relationships are expected to significantly strengthen CLMBR's position in the UK
Read More
The Coalition for Patient Rights, Integrative Providers Association, and Compassion Center strongly oppose Nevada's AB76, which threatens access to vital cannabis-based therapies by misclassifying widely used extraction methods as "synthetic." This legislation endangers patients who rely on concentrates, undermines scientific integrity, and expands regulatory overreach. Advocates urge lawmakers to amend the bill and protect patient rights.
Read More
SIDHE and CIFR, in collaboration with Compassion Center Denver, present exclusive pre- and post-Psychedelic Science events, offering a deep dive into the future of plant-based medicine and psychedelic research. Featuring a recorded lecture from a leading educator, networking with industry pioneers, and private investment showcases, these gatherings provide an unprecedented look at transformative opportunities in psychedelic-assisted therapies and institutional investments shaping the field’s future.
Read MoreAlso Featuring The Sustainable Green Team ($SGTM) with Shark Tank’s Kevin Harrington Showcasing Their WaterLess Garden Product
Read More
Stevenson School, a leading independent PK-12 boarding and day school, today announced the launch of "Reflecting on Our Progress, Inspiring Our Future," a month-long initiative highlighting the school's recent achievements and vision for the future.
Read More
A lawsuit was filed for certain investors in Pacira BioSciences, Inc. (NASDAQ: PCRX) shares. Investors who purchased shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) prior to August 2023 and continue to hold any of those NASDAQ: PCRX shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
A lawsuit was filed for certain investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares. Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and continue to hold any of those NASDAQ:REGN shares, should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read MoreTransaction Highlights the Strategic Transformation of the Company to a Pure Communications SaaS Subscription Model
Transaction creates a focus on the higher growth communications subscription business.
$12.5 million total cash consideration, subject to certain post-closing adjustments, with $12 million paid at closing and $500,000 held back for twelve months. $12 million proceeds will be used to immediately pay down debt.
The asset sale includes the transfer of the entire compliance team of 11 employees and associated client contracts, intellectual property and other related assets.
Refined business model expected to deliver enhanced EBITDA margins.
Includes transition services agreement for up to six months to assist Equiniti with the integration of the compliance business.
